Why Pharmaceutical Companies and Biotechnology Firms Rely on...

added blog Wellness

2026-09-02 07:26:35 -

Why Pharmaceutical Companies and Biotechnology Firms Rely on Preclinical CROs

The global preclinical CRO market is growing as pharmaceutical and biotechnology companies increasingly outsource preclinical research to specialized contract research organizations. The market was valued at USD 6.57 billion in 2024 and is projected to reach USD 11.99 billion by 2035, growing at a CAGR of 5.62%. The Preclinical CRO Market includes biologics testing, small molecule testing,...

0 Comments 0 Shares 73 Views 0 Reviews